Better Therapeutics, Inc. (BTTX)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000099 (-99.00%)
At close: Nov 12, 2026
Better Therapeutics Market Cap
Better Therapeutics has a market cap or net worth of $55 as of November 19, 2026. It is the 53,140th most valuable company in the world and the 9,035th biggest in the United States. Its market cap has decreased by 98.99% in one year.
Market Cap
55.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#9,035 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 17, 2021, Better Therapeutics's market cap has decreased from 66.05M to 55.00, a decrease of -100.00%. That is a compound annual growth rate of -91.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 55.00 | -98.99% |
| Dec 31, 2025 | 5.45K | - |
| Dec 31, 2024 | 5.45K | -99.94% |
| Dec 29, 2023 | 9.24M | -64.77% |
| Dec 30, 2022 | 26.24M | -76.09% |
| Dec 31, 2021 | 109.74M | 66.14% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardax | 83.00 |
| 0913693 B.C. | 74.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Panacos Pharmaceuticals | 54.00 |
| Iterum Therapeutics | 53.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |